Melbourne, Apr 1, 2009 (ABN Newswire) - Mesoblast Limited (ASX:MSB)(PINK:MBLTY) has announced the successful closure of the equity raising that forms the funding package for the expansion of MSB’s clinical programs focusing on bone and cartilage regenerative programs for spinal vertebral disc disease.
